❗️ Why is Big Pharma So Scared of One Small Biotech Firm? | Jul 8, 2024

It isn’t cryptos or pot stocks like most investors think it is. What we’ve come to see as the best opportunity lies in the biotech sector. [Smart Merchant Know]( [Empowering Your Finances with Smart Merchant Know] Dorian Gray glanced at the picture, and suddenly an uncontrollable feeling of hatred for Basil Hallward came over him, as though it had been suggested to him by the image on the canvas, whispered into his ear by those grinning lips. The mad passions of a hunted animal stirred within him, and he loathed the man who was seated at the table, more than in his whole life he had ever loathed anything. He glanced wildly around. Something glimmered on the top of the painted chest that faced him. His eye fell on it. He knew what it was. It was a knife that he had brought up, some days before, to cut a piece of cord, and had forgotten to take away with him. He moved slowly towards it, passing Hallward as he did so. As soon as he got behind him, he seized it and turned round. Hallward stirred in his chair as if he was going to rise. He rushed at him and dug the knife into the great vein that is behind the ear, crushing the man’s head down on the table and stabbing again and again. There was a stifled groan and the horrible sound of some one choking with blood. Three times the outstretched arms shot up convulsively, waving grotesque, stiff-fingered hands in the air. He stabbed him twice more, but the man did not move. Something began to trickle on the floor. He waited for a moment, still pressing the head down. Then he threw the knife on the table, and listened. He could hear nothing, but the drip, drip on the threadbare carpet. He opened the door and went out on the landing. The house was absolutely quiet. No one was about. For a few seconds he stood bending over the balustrade and peering down into the black seething well of darkness. Then he took out the key and returned to the room, locking himself in as he did so. The thing was still seated in the chair, straining over the table with bowed head, and humped back, and long fantastic arms. Had it not been for the red jagged tear in the neck and the clotted black pool that was slowly widening on the table, one would have said that the man was simply asleep. How quickly it had all been done! He felt strangely calm, and walking over to the window, opened it and stepped out on the balcony. The wind had blown the fog away, and the sky was like a monstrous peacock’s tail, starred with myriads of golden eyes. He looked down and saw the policeman going his rounds and flashing the long beam of his lantern on the doors of the silent houses. The crimson spot of a prowling hansom gleamed at the corner and then vanished. A woman in a fluttering shawl was creeping slowly by the railings, staggering as she went. Now and then she stopped and peered back. Once, she began to sing in a hoarse voice. The policeman strolled over and said something to her. She stumbled away, laughing. A bitter blast swept across the square. The gas-lamps flickered and became blue, and the leafless trees shook their black iron branches to and fro. He shivered and went back, closing the window behind him. Hello Fellow American! [Want to hear about the best “hidden” opportunity on Wall Street?]( It isn’t cryptos or pot stocks like most investors think it is. What we’ve come to see as the best opportunity lies in the biotech sector. We’ve now seen a different biotech stock get taken over every 56 days… So, I hope you’ve made good money with us! Today, I’ve decided to reveal some interesting information that most investors don’t know… In particular, I’m going to explain why these big mergers are happening. It started back in 1990, with the Human Genome Project (HGP). Their goal was to map the human genome. One of the benefits of this research was it allowed scientists to identify mutations linked to different types of cancer. After that, they were able to design new medications to address these mutations. [This is where the story gets interesting…]( Because 75% of the cancer drugs still being used are old drugs. The drug to treat Leukemia, for example, is Cytarbine. And Cytarbine was patented way back in 1960. And because it’s an old drug, patients have to suffer through a host of horrible side effects. These include rashes, vomiting, diarrhea, liver issues, bone marrow suppression, bleeding and ulcers of the mouth. Anybody who has dealt with cancer themselves or watched a loved one suffer knows how brutal the experience can be. This is why they say “the chemo will get you before the cancer does.” But the news does get better from here… [Because the HGP showed scientists a “NEW WAY” of fighting cancer. And they’ve been using data from the project to create new treatments.]( Why is this good for takeover investors? Worldwide, around $140 billion was spent on cancer therapies in 2018. And 75% of that was spent on the “OLD WAY” of doing things. Only 25% was spent on the “NEW WAY.” But how long can that last? Not very long. And that is a problem for Big Pharma companies. If they want to maintain their iron-clad grip on the industry, they need to either put together a whole new team to do research and hope they can make a drug that works… Or just buy out smaller biotech companies that are already busy designing these treatments. Recently, a small firm created a “NEW WAY” leukemia treatment. This is a big threat to Novartis and Bristol Myers. [And that’s why this company is our takeover target of the month.]( Just look at the past few months… Pfizer bought “NEW WAY” firm Array Biopharma at $48 a share…which was a 144% gain from our recommended price of $18.90. Glaxo bought Tesaro at $74.96…a big 93% gain from our recommended price of $38.51 Eli Lilly acquired Loxo Oncology for $234.66…a 78% gain from our recommended price of $131.02. Illumina picked up a diagnostic firm called Pacific Biosciences for $8…which was an 82% gain from our recommended price of $4.38. What’s the next “NEW WAY” company to get acquired? [Click here to find out who we predict will be taken over next…and why we think it has the potential to make millions for fast-acting investors.]( "The Buck Stops Here" Dylan Jovine Chairman Behind the Markets [--------------][--------------] Sometimes, colleagues of SMK share special offers with us that we think our readers should be made aware of. Above is one such special opportunity that we believe deserves your attention. [Smart Merchant Know]( Don’t hesitate to reach out to our expert support team for prompt solutions and personalized guidance. Simply send an email to support@smartmerchantknow.com. This email was sent by Smart Merchant Know on behalf of Event Horizon LLC . 435 N Dupont Hwy, Dover, DE 19901, United States Copyright © 2024 Smart Merchant Know. All rights reserved. [PP][Privacy Policy]( [TsC][Terms & Conditions]( [Unsub][Unsubscribe]( [SMK](